<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">34998626</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1768-3122</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>Jan</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>La Revue de medecine interne</Title>
          <ISOAbbreviation>Rev Med Interne</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Pathophysiological and diagnostic aspects of Guillain-Barré syndrome].</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">S0248-8663(21)01146-2</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.revmed.2021.12.005</ELocationID>
        <Abstract>
          <AbstractText>Guillain-Barré syndrome (GBS) is the most common cause of acute neuropathy. It usually onset with a rapidly progressive ascending bilateral weakness with sensory disturbances, and patients may require intensive treatment and close monitoring as about 30% have a respiratory muscle weakness and about 10% have autonomic dysfunction. The diagnosis of GBS is based on clinical history and examination. Complementary examinations are performed to rule out a differential diagnosis and to secondarily confirm the diagnosis. GBS is usually preceded by an infectious event in ≈ 2/3 of cases. Infection leads to an immune response directed against carbohydrate antigens located on the infectious agent and the formation of anti-ganglioside antibodies. By molecular mimicry, these antibodies can target structurally similar carbohydrates found on host's nerves. Their binding results in nerve conduction failure or/and demyelination which can lead to axonal loss. Some anti-ganglioside antibodies are associated with particular variants of GBS: the Miller-Fisher syndrome, facial diplegia and paresthesias, the pharyngo-cervico-brachial variant, the paraparetic variant, and the Bickerstaff brainstem encephalitis. Their semiological differences might be explained by a distinct expression of gangliosides among nerves. The aim of this review is to present pathophysiological aspects and the diagnostic approach of GBS and its variants.</AbstractText>
          <CopyrightInformation>Copyright © 2021 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Carpentier</LastName>
            <ForeName>V T</ForeName>
            <Initials>VT</Initials>
            <AffiliationInfo>
              <Affiliation>Service de médecine Physique et de Réadaptation, Garches, AP-HP, Université Paris Saclay, Hôpital Raymond Poincaré, Paris, France; U1179 END-ICAP, Inserm, UFR Simone Veil-Santé, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Université Paris Saclay, Montigny-le-Bretonneux, France; ISPC Synergies, Paris, France; Groupe de recherche en neuro-orthopédie de Garches (GRENOG), Garches, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Le Guennec</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Sorbonne Université, Unité de Médecine Intensive Réanimation à orientation neurologique, Département de Neurologie, DMU Neurosciences, Hôpital de la Pitié-Salpêtrière, AP-HP.Sorbonne Université, Paris, France; U1016, UMR8104, Institut Cochin, Inserm, CNRS, Université de Paris, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fall</LastName>
            <ForeName>S A A</ForeName>
            <Initials>SAA</Initials>
            <AffiliationInfo>
              <Affiliation>Sorbonne Université, Unité de Médecine Intensive Réanimation à orientation neurologique, Département de Neurologie, DMU Neurosciences, Hôpital de la Pitié-Salpêtrière, AP-HP.Sorbonne Université, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Viala</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Département de Neurophysiologie Clinique, AP-HP, Sorbonne Université, Hôpital de la Pitié-Salpêtrière, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Demeret</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Sorbonne Université, Unité de Médecine Intensive Réanimation à orientation neurologique, Département de Neurologie, DMU Neurosciences, Hôpital de la Pitié-Salpêtrière, AP-HP.Sorbonne Université, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Weiss</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Sorbonne Université, Unité de Médecine Intensive Réanimation à orientation neurologique, Département de Neurologie, DMU Neurosciences, Hôpital de la Pitié-Salpêtrière, AP-HP.Sorbonne Université, Paris, France; Sorbonne Université, Groupe de Recherche Clinique en RÉanimation et Soins intensifs du Patient en Insuffisance Respiratoire aiguË (GRC-RESPIRE), Paris, France; UMR-S 938 Centre de Recherche de Saint-Antoine, INSERM, Sorbonne Université, Paris, France; Sorbonne Université, Brain Liver Pitié-Salpêtrière (BLIPS) Study Group, Paris, France. Electronic address: nicolas.weiss@aphp.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>fre</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Syndrome de Guillain-Barré : physiopathologie et aspects diagnostiques.</VernacularTitle>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>France</Country>
        <MedlineTA>Rev Med Interne</MedlineTA>
        <NlmUniqueID>8101383</NlmUniqueID>
        <ISSNLinking>0248-8663</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Diagnosis</Keyword>
        <Keyword MajorTopicYN="N">Diagnostic</Keyword>
        <Keyword MajorTopicYN="N">Guillain-Barre syndrome</Keyword>
        <Keyword MajorTopicYN="N">Miller-Fisher syndrome</Keyword>
        <Keyword MajorTopicYN="N">Pathophysiology</Keyword>
        <Keyword MajorTopicYN="N">Physiopathologie</Keyword>
        <Keyword MajorTopicYN="N">Syndrome de Guillain-Barré</Keyword>
        <Keyword MajorTopicYN="N">Syndrome de Miller-Fisher</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>9</Day>
          <Hour>20</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34998626</ArticleId>
        <ArticleId IdType="doi">10.1016/j.revmed.2021.12.005</ArticleId>
        <ArticleId IdType="pii">S0248-8663(21)01146-2</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
